CRDL – cardiol therapeutics inc. - class a common shares (US:NASDAQ)

News

Cardiol Therapeutics Inc. (NASDAQ: CRDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Are Medical Stocks Lagging Cardiol Therapeutics (CRDL) This Year? [Yahoo! Finance]
US producer prices unchanged in September [Yahoo! Finance Canada]
Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares [Yahoo! Finance]
Terry Lynch Joins BioNxt as Capital Markets Advisor [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com